(Q46304032)

English

Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/9514453

Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction (English)

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/9514453

unstable angina

1 reference

based on heuristic

inferred from title

myocardial ischemia

1 reference

based on heuristic

inferred from title

author name string

Schwartz GG

1

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/9514453

Oliver MF

2

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/9514453

Ezekowitz MD

3

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/9514453

Ganz P

4

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/9514453

Waters D

5

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/9514453

Kane JP

6

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/9514453

Texter M

7

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/9514453

Pressler ML

8

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/9514453

Black D

9

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/9514453

Chaitman BR

10

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/9514453

Olsson AG

11

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/9514453

language of work or name

0 references

publication date

1 March 1998

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/9514453

American Journal of Cardiology

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/9514453

81

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/9514453

5

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/9514453

578-581

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/9514453

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900963-6

7 January 2021

The electrocardiogram in population studies. A classification system

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900963-6

7 January 2021

Methodology of serial ECG classification using an adaptation of the NOVACODE for Q wave myocardial infarction in the Bypass Angioplasty Revascularization Investigation (BARI).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900963-6

7 January 2021

Prospective comparison of unstable angina versus non-Q wave myocardial infarction during antithrombotic therapy. Antithrombotic Therapy in Acute Coronary Syndromes Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900963-6

7 January 2021

Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900963-6

7 January 2021

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900963-6

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900963-6

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900963-6

7 January 2021

The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900963-6

7 January 2021

One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900963-6

7 January 2021

Physicochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900963-6

7 January 2021

Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. II. Cellular composition and proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900963-6

7 January 2021

Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900963-6

7 January 2021

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900963-6

7 January 2021

Identifiers

10.1016/S0002-9149(97)00963-6

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/9514453

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/9514453

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46304032&oldid=2104243659"